Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It is not a lie! Go read the financial statements. Fees paid to Sheba are included under professional fees. And you may not consider that and R&D but it pretty much is :)
It was never minuscule. Most R&D is done by third parties like Sheba and I've kept saying that even if these fees are a part of G&A, they are technically R&D spending.
I am still saying the same thing here!
For those who has been talking down OWCP's R&D spending, the company spent $245k in 6 months!
This doesn't even include professional fees paid to Sheba and salaries paid to Dr. Baruch!
Amazing 10Q confirms what has been going on.
OWCP paid Medmar so there is ZERO notes to be paid!
Even after paying Medmar $300k, OWCP still has $1.4 million in cash!!!
Another amazing day for VDRM!
#5 and #6 on most posted and most read boards!!!
We hit 3 cents multiple times!
This resistance is soon to be our support for the next step up!
VDRM
Even 6.9 cents is be dead cheap for where this supposed to be!
A conservative MC of $150 million brings the PPS to $.40!
I expect this to be anywhere between $.50 - to $1 by end of the year!
Right on time! We hit 3 cents already as I predicted. Let's see if last half an hour will get us close near 3.2 - 3.5 cents range!
VDRM!
This should build higher steps in the next hour and then in the last half an hour before close.
I expect we hit 3 cents in an hour and close near 3.2-3.5 cents today!
$VDRM
MC is ridiculously low!
About 7.5 million volume in 15 minutes! Great start!
This may close over 3 cents today but much more to come in the near term!
$VDRM
Amazing close near HOD! Congrats to everyone but next week is gonna be much more amazing!!!
$VDRM
Once we break 21, next stop is 25!
$VDRM
I say we see .025 before the bell!!!
Here we go, next leg up started!!!
$VDRM
He told me not buy over .34 and sell above .37 and I got confused! LOL!
Getting more and more attention every minute. Many will hear about the news over the weekend and will jump on VDRM Monday morning.
This is ridiculously undervalued with $12 million projected sales only in Japan!
RSI cooled off and ready for the next step up! I say we hit .025!
$VDRM
BREAKOUT MODE!!!
Here weeeeee go! Beating new HODs back to back!!!
Reversal is so clear! Looking at the daily chart, I foresee OWCP to breach the 50-day moving average in a 100% bullish manner.
Once that happens, huge volume should flow in regardless of news. This can fly back to .75 to $1 within a week or two IMO!
OWCP
Mods, can we get the news stickied?
SOURCE: ViaDerma, Inc.
August 18, 2017 08:00 ET
ViaDerma, Inc. Set to Begin Sales of its FDA Registered Topical Antibiotic in September with Initial Orders from Japan
Viaderma, Inc. announces Galaxy Solutions, Inc. as new sales representative for select Asia Pacific markets
LOS ANGELES, CA--(Marketwired - August 18, 2017) - ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, announced today that it has appointed Galaxy Solutions, Inc. as its sales representative for its first aid topical antibiotic which will be sold under the brand name Vitastem in select markets of Asia Pacific, starting in Japan. The agreement includes sales and marketing responsibilities of the Vitastem brand and possible other brands that will be developed for specific market segments. Galaxy Solutions, Inc. will work to sell directly to larger customers and to distributors and will be the primary provider of service and support in the covered markets.
"With Galaxy Solutions as our sales representative, we will immediately have access to the professional segment of our target markets," said Dr. Chris Otiko, CEO of Viaderma, Inc. "Our goal is to continuously increase our revenues and improve our customers' experience in every aspect. Expanding our network of sales and support personnel and being in close proximity to where our customers are is a key initiative towards achieving that. With competitive pricing for retail sales through doctor's offices in Japan, the Company is conservatively estimating 2018 sales in Japan alone at approximately $12 million US dollars."
"Over the last 7 years Galaxy Solutions has established itself as a premier supplier of epidermal healing solutions, anti-aging solutions and beautification solutions. The relationship with Galaxy Solutions, Inc. will allow us to introduce our products to several markets, initially in Japan and then throughout Asia Pacific, immediately," said Otiko.
"Product testing has already begun and we are expecting to place an initial order in the next 30-45 days. I expect sales to be at around 10,000 units per month in the first 4-6 months and we hope to double that to 20,000 units per month in 2018 in Japan alone. The current testing is being done on sores resulting form side effects of cancer treatments and this will be our initial market, next we expect to introduce a product for acne," said Don Heath, President and CEO of Galaxy Solutions, Inc.
About ViaDerma, Inc.
ViaDerma, Inc. (OTC PINK: VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. ViaDerma's products use an innovative transdermal delivery method that allows for application of active ingredients in a topical form. This patent-pending dual carrier transdermal technology may be applied in products within the medical and cosmetic markets. Also, a patent application using the combination of CBD's and THC with the delivery system was filed in 2017. The use of CBD's is for the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Cohn's disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis. For more information, please visit: www.viadermalicensing.com.
About Galaxy Solutions, Inc.
Galaxy Solutions, Inc. is run by its CEO, Don Heath, a veteran in the area of product positioning and sales. After a successful career developing strategic global sales initiatives for fortune 100 companies in the 1980's, 90's and early 2000's, Don decided that he would move to Japan and set up his own Sales Representation company. Today, Don has developed deep relationships with retailers and distributors throughout Asia Pacific and has introduced many products to the Asia Pacific Market.
Forward-Looking Statements
Forward-Looking Statements certain statements in this release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified using words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "intend," and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. The Company's future operating results are dependent upon many factors, including but not limited to the Company's ability to: (i) obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) build the management and human resources and infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company's control; and (iv) other risk factors. We assume no obligation to update the information contained in this news release.
CONTACT INFORMATION
Contact information:
Investor Relations
Email: info@viadermalicensing.com
Phone: 310-734-6111
That is why I said "minimum" :)
$VDRM
$.10 brings the MC to $38 million. Still undervalued IMO. My minimum target price for this is .15 - .20 by September/October
$VDRM
"The Company is conservatively estimating 2018 sales in Japan alone at approximately $12 million US dollars."
The $5 million MC is extremely undervalued!!!
Let's fly, shall weeeeeeeeeeeee?
Yes they did make an offer and OWCP had no interest in selling!
Very good analysis because no one was aware of this LOL!
Keep wishing! LOL
5-10 million volume may be enough to bring this back to a dollar in one trading day!
I truly believe yesterday's last 30 minutes was an indication of good news coming and volume will come with it!
OWCP
No patents have been rejected! There are opinions on some old patent applications but there are two brand new utility patent applications with USPTO and the European patent office!
Simply an amazing day but it only an indication of what is coming up!
$OWCP
Exactly, this is the smartest and most efficient way a non revenue generating startup can operate. It is hell of a difficult business model to operate but OWCP management has been very successful so far!
This is an amazing and a strong step towards removing CBD from schedule 1.
When this happens, which I expect in a year, MMJ stocks will skyrocket like no one has ever seen!
OWCP
Total nonsense!
Clinical trials are not done to impress to shareholders. Sheba is one of the best medical organizations in Israel and yes they need OWCP because they are getting paid to do the trials.
Read the top of the page on the links you provided: it says "American Friends of Sheba". LOL!
I agree that they are both friends of Sheba Israel and America are indeed nonprofit fundraising arms of Sheba and they are equally credible. With that, OWCP's info on one confirms the collaboration.
But even if it doesn't, there is an effin signed contract attached to the 8k. You're wasting your time :)
Dude the website you provided links was also for Friends of Sheba!